End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
21.05 INR | -0.71% | -7.06% | -29.60% |
30/05 | Lasa Supergenerics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 | CI |
26/04 | Lasa Supergenerics CFO Steps Down | MT |
Business Summary
Number of employees: 89
Sales per Business
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Active Pharmaceutical Ingredient Bulk Drugs Products
100.0
%
| 1,371 | 100.0 % | 1,296 | 100.0 % | -5.51% |
Sales per region
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
India
100.0
%
| 1,371 | 100.0 % | 1,296 | 100.0 % | -5.51% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 43 | 11/16/11 | |
Sunil Sitale
ADM | Chief Administrative Officer | - | - |
Compliance Officer | 37 | 21/23/21 | |
Hitesh Wadhwani
LAW | General Counsel | - | - |
Vijay Bhat
SAM | Sales & Marketing | - | 01/10/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 43 | 11/16/11 | |
Director/Board Member | 63 | 02/17/02 | |
Director/Board Member | 35 | 02/17/02 | |
Director/Board Member | - | 02/17/02 | |
Director/Board Member | - | 02/17/02 | |
Director/Board Member | - | 12/18/12 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 50,101,239 | 18,022,513 ( 35.97 %) | 0 | 35.97 % |
Company contact information
Lasa Supergenerics Ltd.
Office No: 705, Minerva Estate A Wing, 02 Commercial Tower
400080, Mumbai
+
Sector
1st Jan change | Capi. | |
---|---|---|
-29.60% | 1.27Cr | |
-12.67% | 7.87TCr | |
+24.25% | 368.1Cr | |
-2.36% | 321.18Cr | |
+17.23% | 177.04Cr | |
-25.26% | 124.17Cr | |
-0.39% | 133.19Cr | |
-28.25% | 119.99Cr | |
-19.82% | 104.85Cr | |
-9.15% | 95Cr |
- Stock Market
- Equities
- LASA Stock
- Company Lasa Supergenerics Limited